[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337367-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337367-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","plod3-facilitated-t-cell-activation-in-the-colorectal-tumor-microenvironment-and-liver-metastasis-by-the-tnf-nf-b-pathway-research-open-access","PLOD3 facilitated T cell activation in the colorectal tumor microenvironment and liver metastasis by the TNF-α/ NF-κB pathway - Research Open Access","","Colorectal cancer (CRC) remains a major global malignancy, and liver metastasis is a decisive driver of poor prognosis. This study examined PLOD3 expression and function in CRC. Mouse models were created by introducing PLOD3 knockdown or overexpression CRC cells (CT26 or MC38) into mouse spleens to assess tumorigenicity and metastatic capacity in vivo. PLOD3 was overexpressed in CRC liver metastasis, correlating with worse survival. PLOD3 knockdown suppressed CRC proliferation, migration, invasion, and liver metastasis, whereas overexpression promoted tumor progression. Mechanistically, PLOD3 facilitated T cell activation in the tumor microenvironment via the TNF-α/NF-κB pathway.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/plod3-facilitated-t-cell-activation-in-the-colorectal-tumor-microenvironment-and-liver-metastasis-by-the-tnf-nf-b-pathway-research-open-access/337367/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/plod3-facilitated-t-cell-activation-in-the-colorectal-tumor-microenvironment-and-liver-metastasis-by-the-tnf-nf-b-pathway-research-open-access/337367.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-15","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is PLOD3’s relationship to liver metastasis in colorectal cancer?","Question",{"text":63,"@type":64},"PLOD3 is significantly overexpressed in liver metastasis samples from CRC, and high PLOD3 expression is associated with poorer patient survival.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were PLOD3 functions tested in vivo?",{"text":68,"@type":64},"Different liver metastasis mouse models were established by injecting PLOD3 stable knockdown or overexpression CT26 or MC38 CRC cells into mouse spleens to evaluate tumor growth and metastasis.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism links PLOD3 to immune activity and metastasis?",{"text":72,"@type":64},"Further experiments indicate that PLOD3 facilitates T cell activation in the tumor microenvironment and affects the TNF-α/NF-κB pathway.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337367,1790146166,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":109,"preview_page_count":33,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Ding et al. Journal of Translational Medicine (2024) 22:30  \n[https://doi.org/10.1186/s12967-023-04809-w](https://doi.org/10.1186/s12967-023-04809-w)  \nJournal of Translational Medicine  \n RESEARCH Open Access  \nPLOD3 facilitatedT cell activation    \nin the colorectal tumor microenvironment and liver metastasis by the TNF-α/ NF-κB pathway  \nMin Ding1,2,3,4†, Cheng Wang1†, Junhong Hu5†, Junjun She3†, Ruoyu Shi6, Yixuan Liu1, Qi Sun7, Haojun Xu1, Guoren Zhou8*, Wenlan Wu8* and Hongping Xia1,2,3*  \nAbstract  \nBackground Colorectal cancer (CRC) has been the third most prevalent cancer worldwide. Liver metastasis  \nis the critical factor for the poor prognosis of CRC. Here, we investigated the expression and role of PLOD3 in CRC. Methods Different liver metastasis models were established by injecting PLOD3 stable knockdown or overexpression CT26 or MC38 mouse CRC cells into the spleen of mice to verify the tumorigenicity and metastasis ability in vivo. Results We identified PLOD3 is significantly overexpressed in liver metastasis samples of CRC. High expression of PLOD3 was significantly associated with poor survival of CRC patients. The knockdown of PLOD3 exhibited remarkable inhibition of proliferation, migration, and invasion in CRC cells, while the opposite results could be found in different PLOD3-overexpressed CRC cells. Stable knockdown of PLOD3 also significantly inhibited liver metastasis of CRC cells in different xenografts models, while stable overexpression of PLOD3 promotes liver metastasis and tumor progression. Further studies showed that PLOD3 facilitated the T cell activation in the tumor microenvironment and affected the TNF-α/ NF-κB pathway.  \nConclusions This study revealed the essential biological functions of PLOD3 in colon cancer progression and metastasis, suggesting that PLOD3 is a promising translational medicine target and bioengineering targeting PLOD3 overcomes CRC liver metastasis.  \nKeywords PLOD3, Colorectal cancer, Liver metastasis, Proliferation, NF-κB  \n†Min Ding, Cheng Wang, Junhong Hu and Junjun She have contributed equally to this work.  \n*Correspondence:  \nGuoren Zhou [zhouguoren888@njmu.edu.cn](zhouguoren888@njmu.edu.cn)[ ](zhouguoren888@njmu.edu.cn)Wenlan Wu [wenlanwu@njmu.edu.cn](wenlanwu@njmu.edu.cn)[ ](wenlanwu@njmu.edu.cn)Hongping Xia [101013473@seu.edu.cn](101013473@seu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http://creativeco](http://creativeco)[mmons.org/publicdomain/zero/1.0/](mmons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nDing et al. Journal of Translational Medicine (2024) 22:30 Page 2 of 16  \nGraphical Abstract  \nIntroduction  \nColorectal cancer (CRC) has been the third most prevalent worldwide after breast and lung cancer. In 2020,","cbCaitmlQR6wuuse","https://ap.wps.com/l/cbCaitmlQR6wuuse","pdf",10127286,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Epidemiology and need for mechanism-based control\n## PLOD family and rationale for PLOD3","[{\"question\":\"What is PLOD3’s relationship to liver metastasis in colorectal cancer?\",\"answer\":\"PLOD3 is significantly overexpressed in liver metastasis samples from CRC, and high PLOD3 expression is associated with poorer patient survival.\"},{\"question\":\"How were PLOD3 functions tested in vivo?\",\"answer\":\"Different liver metastasis mouse models were established by injecting PLOD3 stable knockdown or overexpression CT26 or MC38 CRC cells into mouse spleens to evaluate tumor growth and metastasis.\"},{\"question\":\"What mechanism links PLOD3 to immune activity and metastasis?\",\"answer\":\"Further experiments indicate that PLOD3 facilitates T cell activation in the tumor microenvironment and affects the TNF-α/NF-κB pathway.\"}]","PLOD3 facilitated T cell activation in the colorectal tumor microenvironment and liver metastasis by the TNF-α/ NF-κB pathway - Research Open Access | PDF",1790018824,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c6ee079d10708003ae6ede2d8273868.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dfb2a1b613974a91c03f6823c44bae71.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e61b98c1cdc161299cb46b53e532323.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8f4234d0eab39c4ea5a59f4b66dac054.webp",980,1301]